A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss

Peer Review reports

Original Submission
23 Apr 2008	Submitted	Original manuscript
9 Oct 2008	Reviewed	Reviewer Report - Terry Lewin
20 Nov 2008	Reviewed	Reviewer Report - William Hargreaves
12 Dec 2008	Author responded	Author comments - Maarten Treur
Resubmission - Version 2
12 Dec 2008	Submitted	Manuscript version 2
5 Feb 2009	Reviewed	Reviewer Report - Terry Lewin
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
18 Feb 2009	Editorially accepted
18 Feb 2009	Article published	10.1186/1472-6963-9-32

Back to article page